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Abstract 
Background 
Chronic pain has a strong association with major depressive disorder (MDD), but there is a 
relative paucity of studies on the association between chronic multisite pain and bipolar 
disorder (BD). Such studies are required to help elucidate the complex biological and 
psychological overlap between pain and mood disorders. The aim of this study is to 
investigate the relationship between chronic multisite pain and mood disorder across the 
unipolar-bipolar spectrum. 
Methods 
We conducted a cross-sectional study of 149,611 UK Biobank participants. Self-reported 
depressive and bipolar features were used to categorise participants into MDD and BD 
groups and a non-mood disordered comparison group. Multinomial logistic regression was 
used to establish whether there was an association between extent of chronic pain 
(independent variable) and mood disorder category (dependent variable), using no pain as the 
referent category, and adjusting for a wide range of potential sociodemographic, lifestyle and 
comorbidity confounders. 
Results 
Multisite pain was significantly more prevalent in participants with BD and MDD, for 
example, 4–7 pain sites: BD 5.8%, MDD 4.5%, and comparison group 1.8% (p < 0.001). A 
relationship was observed between extent of chronic pain and risk of BD and persisted after 
adjusting for confounders (relative to individuals with no chronic pain): 2–3 sites RRR of BD 
1.84 (95% CI 1.61, 2.11); 4–7 sites RRR of BD 2.39 (95%CI 1.88, 3.03) and widespread pain 
RRR of BD 2.37 (95%CI 1.73, 3.23). A similar relationship was observed between chronic 
pain and MDD: 2–3 sites RRR of MDD 1.59 (95%CI 1.54, 1.65); 4–7 sites RRR of MDD 
2.13 (95%CI 1.98, 2.30); widespread pain RRR of MDD 1.86 (95%CI 1.66, 2.08). 
Conclusions 
Individuals who report chronic pain and multiple sites of pain are more likely to have MDD 
and are at higher risk of BD. These findings highlight an important aspect of comorbidity in 
MDD and BD and may have implications for understanding the shared neurobiology of 
chronic pain and mood disorders. 
Keywords 
Major depression, Bipolar disorder, Chronic pain, Comorbidity 
Background 
Chronic pain is known to be associated with depressive features and major depressive 
disorder (MDD) [1,2] but the association between chronic pain and bipolar disorder (BD) has 
received less attention. Very few studies have investigated associations between chronic 
multisite pain (pain occurring at two or more body sites [3]) and mood disorders, although 
there is some evidence of a positive correlation between number of chronic pain sites and 
depressive features [4]. 
A study of the health records of 5 million US Veterans Affairs patients found that those with 
MDD or BD were 1.8 and 2.6 times more likely, respectively, to have a diagnosis of one or 
more painful conditions in their health records than non-mood disordered controls [5]. The 
prevalence of chronic pain was reported to be 23.7% in a meta-analysis of chronic pain in BD 
studies; and patients with BD were found to be at a two-fold increased risk of having chronic 
pain compared to the general population [6]. Two further studies investigating the association 
between chronic pain and BD suggested that pain may be under-recognised among 
individuals with BD. Cerimele and colleagues have reported that in a cohort of primary care 
patients receiving an intervention for BD 46% were also receiving treatment for pain or 
experiencing pain that interfered with their daily functioning [7]. In the Singapore Mental 
Health Study, chronic pain was the most prevalent comorbid physical condition among 
participants with BD, affecting 40.4% of these individuals [8]. These initial findings support 
the need for a better understanding of the relationships between chronic pain and mood 
disorder in order to improve the clinical management of these challenging to treat conditions. 
Further epidemiological understanding will lead to the development of biological hypotheses 
that might explain why chronic pain and mood disorder (depression and/or bipolar disorder) 
commonly co-occur. 
UK Biobank is a large, prospective cohort study of over 500,000 participants recruited from 
the general population in England, Scotland and Wales [9]. It represents a unique opportunity 
to investigate associations (and, in future, health outcomes such as onset and prognosis of 
disease, and shared neurobiological and genetic components) between chronic pain 
syndromes and mood disorders. The extent of baseline data collected also makes it possible 
to take account of a wide range of potential confounders including sociodemographic, 
lifestyle, psychological and medical comorbidity factors. 
In this cross-sectional study, we use baseline UK Biobank data to compare the nature and 
extent of chronic pain among participants with features of MDD and BD compared to those 
without significant mood disorder features. We hypothesized that multisite and widespread 
chronic pain would be common in MDD and possibly more common in BD, relative to the 
comparison group, and that these relationships would be independent of potential 
confounding factors. 
Methods 
Study design 
UK Biobank is a large, population-based cohort of approximately 502,600 UK residents aged 
40–69 years at recruitment. It is one of the world’s largest Biobank cohorts, designed to 
investigate the aetiology, prognosis, detection and management of a large number of chronic 
conditions over time [9]. At baseline assessment, all participants provided detailed self-
reported information on demographics, health and lifestyle factors, alongside physical 
measurements, and blood, saliva and urine samples, which will be analysed in future studies. 
The current study uses baseline data on 172,745 participants who completed detailed 
questions on lifetime depressive and manic features. These mood disorder assessments were 
added during the final two years of UK Biobank recruitment (2008–2010), representing 
34.4% of the cohort. 
Participants and data collection 
All adults registered with the UK National Health Service, who were aged 40–69 years and 
lived within 25 miles of one of 22 assessment centres across the UK, were invited to 
participate in UK Biobank [10]. Individuals who agreed to participate attended the 
assessment centre where they provided full informed consent. Participants then completed a 
detailed touch-screen questionnaire which gathered demographic, lifestyle and medical 
information and undertook a nurse-led interview which gathered more detailed information 
on medical conditions and medications. Details of the data used in this study are provided 
below. 
Classification of mood disorder 
We have previously reported on the classification and internal validity of probable MDD and 
BD within UK Biobank, using the self-reported data collected via the baseline touch-screen 
questionnaire [11]. These diagnostic classifications are summarised below in the “Detailed 
information of the UK Biobank variables used for classifying lifetime experience of probable 
bipolar disorder and depression” subsection. In brief, BD included participants who met the 
criteria for BD type I or type II; MDD included participants who met the criteria for recurrent 
severe, recurrent moderate or single episode depression; and all other participants who 
provided complete data comprised the non-mood disordered comparison group, that is they 
were free of probable MDD and BD according to our criteria. Mood groups were mutually 
exclusive; participants who met criteria for both BD and MDD were included in the BD 
group. For ease of reference the term “mood disorder groups” is used throughout the 
manuscript to refer to the three groups of interest – non-mood disordered comparison group, 
probable MDD and probable BD. These classifications were based on a lifetime history of 
manic and depressive symptoms. 
Detailed information of the UK Biobank variables used for classifying lifetime 
experience of probable bipolar disorder and depression 
Criteria for a classification of lifetime experience of probable bipolar disorder: 
1. Bipolar disorder, type I: Ever ‘manic or hyper’ for 2 days OR ever 
‘irritable/argumentative’ for 2 days; plus at least 3 features from ‘more active’, ‘more 
talkative’, ‘needed less sleep’ and ‘more creative/more ideas’; plus duration of a week or 
more; plus ‘needed treatment or caused problems at work’. 
2. Bipolar disorder, type II: Ever ‘manic or hyper’ for 2 days OR ever 
‘irritable/argumentative’ for 2 days; plus at least 3 features from ‘more active’, ‘more 
talkative’, ‘needed less sleep’ and ‘more creative/more ideas’; plus duration of a week or 
more. 
Criteria for a classification of lifetime experience of probable depression: 
1. Single probable episode of major depression: Ever depressed/down for a whole week; 
plus at least two weeks duration; plus only one episode; plus ever seen a GP or a 
psychiatrist for ‘nerves, anxiety, depression’ OR ever anhedonic (unenthusiasm/uninterest) 
for a whole week; plus at least two weeks duration; plus only one episode; plus ever seen a 
GP or a psychiatrist for ‘nerves, anxiety, depression’. 
 
2. Probable recurrent major depression (moderate): Ever depressed/down for a whole 
week; plus at least two weeks duration; plus at least two episodes; plus ever seen a GP (but 
not a psychiatrist) for ‘nerves, anxiety, depression’ OR ever anhedonic 
(unenthusiasm/uninterest) for a whole week; plus at least two weeks duration; plus at least 
two episodes; plus ever seen a GP (but not a psychiatrist) for ‘nerves, anxiety, depression’. 
 
3. Probable recurrent major depression (severe): Ever depressed/down for a whole week; 
plus at least two weeks duration; plus at least two episodes; plus ever seen a psychiatrist 
for ‘nerves, anxiety, depression’ OR ever anhedonic (unenthusiasm/uninterest) for a whole 
week; plus at least two weeks duration; plus at least two episodes; plus ever seen a 
psychiatrist for ‘nerves, anxiety, depression’. 
Classification of chronic and multisite pain 
At baseline assessment, participants were asked the question “In the last month have you 
experienced any of the following that interfered with your usual activities?” The response 
options related to seven specific sites of pain: headache, facial, neck or shoulder, back, 
stomach or abdominal, hip, and knee pain; and an eighth option of “pain all over the body”. 
Participants were permitted to select multiple options unless they reported having pain all 
over the body. Participants who indicated that they had pain were then asked whether the pain 
at each site had been present for more than 3 months (defined as chronic pain). Individuals 
were considered to have chronic multisite pain if they reported chronic pain in two body sites 
or more [3]. The chronic pain categories used for this study were: free of chronic pain; 
chronic single site pain; chronic pain at 2–3 sites; chronic pain at 4–7 sites; and chronic pain 
all over the body (widespread pain). Widespread pain was considered as a separate category 
because a participant who selected ‘pain all over the body’ may differ from one who selected 
seven individual sites of pain. 
Confounding factors 
We considered sociodemographic factors, lifestyle factors and medical comorbidities as 
important potential confounders of the relationship between chronic pain syndromes and 
mood disorder. The sociodemographic factors included as covariates were: sex, age (as a 
continuous variable), ethnic group (defined by UK Biobank as white, black or black British, 
Asian or Asian British and other (including mixed, Chinese and other ethnic group)), 
employment status and area-based socioeconomic deprivation. Participants could select more 
than one option for their current employment status and for this study were categorised into 
mutually exclusive groups: paid employment/looking after home or family, retired (unless 
also selected not working due to sickness), unemployed/unpaid, not working due to sickness 
or disability, and student (if they selected no other category). Area-based socioeconomic 
status was assessed using the Townsend Index, a score derived from postcode of residence 
information on unemployment, car ownership, owner occupation and overcrowding [12]. A 
higher Townsend Index score reflects higher levels of deprivation. The Townsend score was 
categorised into quintiles based on frequency in this study population: quintile 1 represents 
the least deprived and quintile 5 the most deprived areas. Lifestyle factors considered as 
potential confounders included: body mass index (BMI) based on actual weight and height 
measurements taken at the assessment centre and categorised into: underweight <18.5 kg/m
2
, 
normal weight = 18.5-24.9 kg/m
2
, overweight =25.0-29.9 kg/m
2, and obese ≥ 30.0 kg/m2 
[13]; smoking status (current, former or never smokers); and frequency of alcohol 
consumption (daily/almost daily, 3–4 times per week, 1–2 times per week, 1–3 times per 
month, special occasions only and never). Doctor-diagnosis of cancer was self-reported using 
the touch screen questionnaire, and details of participants’ other medical conditions were 
based on self-report during a face to face interview with a trained nurse (UK Biobank field ID 
20002). Based on previous work on multimorbidity in large population samples [14], a total 
of 43 long-term conditions were also classified (see Additional file 1: Table S1 for full 
details). For this study, painful conditions and psychiatric/depressive conditions were 
excluded, resulting in a total of 36 chronic comorbid conditions being considered. A count of 
medical comorbidities was constructed for each participant. 
Ethical approval 
Participants provided full informed consent to participate in UK Biobank. This study was 
covered by the generic ethical approval for UK Biobank studies from the NHS National 
Research Ethics Service (approval letter dated 17
th
 June 2011, Ref 11/NW/0382). 
Statistical analysis 
Initial descriptive analyses compared the extent of pain, demographic and lifestyle factors, 
and medical morbidity across the three mood disorder groups: BD, MDD and comparison 
(free of MDD and BD). Multinomial logistic regression models were constructed to quantify 
the relationship between the extent of chronic pain (independent variable) and mood disorder 
(dependent variable) relative to the comparison group. In order to examine the relative 
contribution of each group of putative confounding variables, four models were constructed: 
1) no adjustment; 2) adjustment for demographic variables (age, sex, ethnicity, 
socioeconomic status); 3) as in model 2 plus lifestyle factors (BMI, smoking status and 
frequency of alcohol consumption); and 4) as in model 3 plus number of long-term 
conditions. In addition, possible interactions between the extent of pain and sex were 
formally tested in the unadjusted model (model 1). Results are presented as relative risk ratios 
(RRR) and 95% confidence intervals (95% CI). Binary logistic regression models were also 
constructed to quantify the relationship between the extent of chronic pain and BD relative to 
MDD; this analysis excluded participants in the comparison group. Four logistic regression 
models were constructed with identical levels of adjustment as those described above. The 
results are presented as odds ratios (OR) and 95% CI. All analyses were conducted using 
Stata V13.0 (StataCorp, College Station, Texas). Since the data were at least 99% complete 
for all variables used in this study imputation was not required; the number in each regression 
model varied according to the number of participants with complete data for the included 
variables. 
Results 
Study population 
Of the 172,745 participants who were asked questions on lifetime history of depressive and 
manic features, 149,842 (86.7%) remained in the study and could be classified into one of the 
three mood disorder groups. Of these, 149,611 (99.8%) provided complete data on chronic 
pain status and constituted the study population. The study population was 53.3% female and 
the mean age was 56.7 years (standard deviation (SD) 8.2). 
Prevalence and characteristics of mood disorder groups 
Of the 149,611 participants included in the analysis, 31,814 (21.3%) were classified as MDD 
and 1,613 (1.1%) as BD and the remaining 116,184 (77.7%) comprised the non-mood 
disordered comparison group. The proportion of participants reporting single-site chronic 
pain was similar across the three groups (22.4%-24.3%; Table 1 and Figure 1). Although not 
a question of our analysis, it should be noted that all six regional sites of pain were most 
common in the BD group, second to the MDD group and then the comparison group. 
Similarly the prevalence of multisite pain (two or more sites or whole body) increased across 
the three groups from comparison group (15.8%) through MDD (26.1%) to BD (31.7%). 
Table 1 and Figure 1 provide further detail on the number and proportion of participants in 
each of the multisite pain categories across the groups; with the proportion reporting 2–3 
sites, 4–7 sites and widespread pain clearly increasing from the comparison group, through 
MDD group to BD group. 
Table 1 Characteristics of participant according to mood disorder groups 
 Mood group* 
N = 149,611^ 
 Comparison group Probable depression Probable bipolar disorder 
N = 116,184^ N = 31,814^ N = 1,613^ 
 N (%) N (%) N (%) 
Chronic pain status    
No chronic pain 71,800 (61.8) 15,766 (49.6) 729 (45.2) 
1 site 26,061 (22.4) 7,736 (24.3) 373 (23.1) 
2-3 sites 15,285 (13.2) 6,299 (19.8) 365 (22.6) 
4-7 sites 2,068 (1.8) 1,416 (4.5) 93 (5.8) 
Widespread pain 970 (0.8) 597 (1.9) 53 (3.3) 
Female 58,395 (50.3) 20,490 (64.4) 790 (49.0) 
Townsend Index quintiles    
1 (least deprived) 23,749 (20.5) 5,930 (18.7) 211 (13.1) 
2 23,724 (20.5) 5, 921 (18.7) 213 (13.2) 
3 23,324 (20.1) 6,285 (19.8) 267 (16.6) 
4 23,004 (19.8) 6,507 (20.5) 364 (22.6) 
5 (most deprived) 22,208 (19.1) 7,106 (22.4) 557 (34.6) 
Ethnicity    
White 105,746 (91.4) 29,957 (94.5) 1,421 (88.8) 
Asian/Asian British 3,955 (3.4) 584 (1.8) 66 (4.1) 
Black/Black British 3,358 (2.9) 539 (1.7) 53 (3.3) 
Other 2,683 (2.3) 623 (2.0) 61 (3.8) 
Employment status    
In paid employment/ look after home 66,418 (57.7) 18,111 (57.4) 880 (55.2) 
Retired 42,985 (37.4) 10,403 (33.0) 401 (25.1) 
Unemployed / unpaid 2,888 (2.5) 969 (3.1) 77 (4.8) 
Not working due to sick 2,538 (2.2) 1,910 (6.1) 228 (14.3) 
Student 269 (0.2) 140 (0.4) 9 (0.6) 
Smoking status    
Never 66,360 (57.3) 15,988 (50.4) 686 (42.7) 
Former 42,139 (36.4) 12,721 (40.1) 633 (39.4) 
Current 7,288 (6.3) 3,036 (9.6) 286 (17.8) 
Frequency of alcohol intake    
Daily/almost daily 24,246 (20.9) 6,281 (19.8) 326 (20.3) 
3-4 times/week 27,110 (23.4) 6,720 (21.1) 267 (16.6) 
1-2 times/week 29,736 (25.6) 7,653 (24.1) 352 (21.9) 
1-3 times/month 12,624 (10.9) 4,053 (12.8) 201 (12.5) 
Special occasions only 13,130 (11.3) 4,213 (13.3) 243 (15.1) 
Never 9,279 (8.0) 2,878 (9.1) 220 (13.7) 
BMI categories    
Underweight 558 (0.5) 161 (0.5) 15 (1.0) 
Normal weight 38,218 (33.1) 9,950 (31.5) 460 (28.8) 
Overweight 49,574 (43.0) 12,806 (40.5) 631 (39.5) 
Obese 27,08 (23.4) 8,674 (27.5) 490 (30.7) 
 Mean (SD) Mean (SD) Mean (SD) 
Age in years 57.03 (8.2) 55.70 (8.0) 54.4 (8.1) 
Morbidity count 0.88 (1.0) 1.09 (1.2) 1.15 (1.2) 
^ Overall number varies by the amount of missing data but 149,611 participants were eligible for analysis 
* Differences between groups were statistically significant at p < 0.001 for all variables (tests by Chi
2
 test for 
categorical variables and Kruskal Wallis test for continuous variables). 
SD – standard deviation; BMI – body mass index. 
Figure 1 Prevalence of chronic pain by mood group. Bar chart depicting the proportion of 
participants in each of the multisite pain categories for each of the three mood disorder 
groups of interest. 
The sociodemographic, lifestyle and morbidity characteristics of the groups are also reported 
in Table 1. Women comprised around half of the comparison and BD groups but almost two 
thirds of the MDD group. The mean age across the groups decreased from the comparison 
group through MDD to BD. Other notable differences included a greater proportion of the 
BD group being in the most deprived quintile of socioeconomic status compared to the MDD 
and comparison groups. Similarly, a greater proportion of the BD group compared to the 
MDD and comparison groups were not working due to sickness or disability, were current 
smokers, regarded themselves as “never” drinkers and were classified as obese. The mean 
number of medical morbidities showed a similar direction of relationship from BD through 
MDD to the comparison group (1.2, 1.1 and 0.9 respectively). 
Association between the extent of chronic multisite pain and mood disorder 
The univariate multinomial regression model (model 1) confirmed that the likelihood of 
being classified as having a mood disorder (MDD or BD) increased with increasing number 
of sites affected by pain (Table 2). There was also a possible dose relationship whereby the 
likelihood of having BD (compared with MDD or no mood disorder) increased with number 
of pain sites. 
Table 2 Multinomial logistic regression models of the association between the extent of chronic multisite pain and mood disorder 
  RRR (95% CI)* 
Model  Probable depression Probable bipolar 
1. No adjustments (n = 149,612) No chronic pain 1 1 
1 site 1.35 (1.31, 1.39) 1.41 (1.24, 1.60) 
2-3 sites 1.88 (1.81, 1.94) 2.35 (2.07, 2.38) 
4-7 sites 3.12 (2.91, 3.34) 4.43 (3.55, 5.52) 
Widespread pain 2.80 (2.53, 3.11) 5.38 (4.04, 7.16) 
2. Adjusted for sex, age, ethnicity, deprivation and employment status 
(n = 147,463) 
No chronic pain 1 1 
1 site 1.32 (1.28, 1.37) 1.34 (1.18, 1.52) 
2-3 sites 1.74 (1.68, 1.80) 2.03 (1.78, 2.31) 
4-7 sites 2.54 (2.36, 2.73) 2.89 (2.29, 3.64) 
Widespread pain 2.23 (1.997, 2.49) 2.81 (2.07, 3.81) 
3. Adjustments as for 2. plus BMI, smoking status and frequency of 
alcohol consumption (n = 145,945) 
No chronic pain 1 1 
1 site 1.30 (1.26, 1.34) 1.29 (1.13, 1.47) 
2-3 sites 1.66 (1.61, 1.72) 1.92 (1.68, 2.19) 
4-7 sites 2.38 (2.21, 2.57) 2.62 (2.07, 3.33) 
Widespread pain 2.07 (1.85, 2.31) 2.61 (1.91, 3.55) 
4. Adjustments as for 3. plus additional long term condition morbidity 
count (n = 145,518) 
No chronic pain 1 1 
1 site 1.27 (1.23, 1.31) 1.27 (1.12, 1.45) 
2-3 sites 1.59 (1.54, 1.65) 1.84 (1.61, 2.10) 
4-7 sites 2.14 (1.99, 2.31) 2.39 (1.88, 3.04) 
Widespread pain 1.86 (1.66, 2.08) 2.37 (1.74, 3.24) 
*Relative to non-mood disordered comparison group. Associations for individual variable level and the overall models were significant at p < 
0.001. 
RRR – relative risk ratio; 95% CI – 95% confidence interval; BMI – body mass index. 
The addition of potential sociodemographic confounders to the models attenuated these 
associations, especially for BD, but all of the associations remained statistically significant (p 
< 0.001). The addition of lifestyle covariates and comorbidity counts further attenuated the 
associations but there remained statistically significant associations between extent of chronic 
pain and both mood disorder groups (and particularly BD) with dose relationships from 0 to 
4–7 pain sites (Table 2 and Figure 2). 
Figure 2 Multinomial logistic regression model of the association between chronic pain 
and mood disorder. Plot of the relative risk ratio and 95% confidence intervals of the 
association between extent of chronic pain and depression and bipolar for a) multinomial 
logistic regression model 1, unadjusted analysis, and b) multinomial logistic regression model 
4, fully adjusted analysis for demographic variables (age, sex, ethnicity, socioeconomic 
status), lifestyle factors (BMI, smoking status and frequency of alcohol consumption), and 
number of long-term conditions. 
There was no significant statistical interaction between sex and the extent of chronic multisite 
pain in relation to mood disorder groups, and therefore subsequent model stratification by sex 
was not carried out. 
Association between extent of chronic multisite pain and BD relative to MDD 
Binary logistic regression models were constructed to quantify the association between the 
extent of chronic multisite pain and BD relative to MDD (rather than the comparison group) 
and are presented in Table 3. Model 1 (unadjusted analysis) found a significant dose–
response relationship, with the odds of BD increasing with increasing extent of chronic pain. 
The odds of having BD increased to 1.92 for the group reporting widespread pain compared 
to no pain. Following adjustment for all confounding variables, this pattern of association 
remained; however, most of the relationships were no longer statistically significant and wide 
confidence intervals were observed. Reporting 2–3 sites of pain was the only category that 
remained significantly associated with having BD relative to MDD following full adjustment 
for all confounding variables (model 4: OR = 1.16). Again, there was no statistical interaction 
observed between chronic pain and sex in relation to mood group. 
Table 3 Logistic regression models of the association between the extent of chronic pain and probable bipolar disorder, relative to 
probable depression 
Model  OR (95% CI* P value^ P value^^ 
1. No adjustments (n = 149,612) No chronic pain 1  <0.001 
1 site 1.04 (0.92, 1.18) 0.520 
2-3 sites 1.25 (1.10, 1.43) 0.001 
4-7 sites 1.42 (1.13, 1.77) 0.002 
Widespread pain 1.92 (1.44, 2.57) <0.001 
2. Adjusted for sex, age, ethnicity, deprivation and employment status (n = 147,463) No chronic pain 1  <0.001 
1 site 1.02 (0.90, 1.17) 0.724 
2-3 sites 1.18 (1.03, 1.34) 0.018 
4-7 sites 1.16 (0.92, 1.47) 0.210 
Widespread pain 1.34 (0.99, 1.83) 0.061 
3. Adjustments as for 2. plus BMI, smoking status and frequency of alcohol 
consumption (n = 145,945) 
No chronic pain 1  <0.001 
1 site 1.01 (0.88, 1.15) 0.898 
2-3 sites 1.15 (1.01, 1.32) 0.039 
4-7 sites 1.11 (0.88, 1.41) 0.372 
Widespread pain 1.32 (0.97, 1.81) 0.079 
4. Adjustments as for 3. plus additional long term condition morbidity count (n = 
145,518) 
No chronic pain 1  <0.001 
1 site 1.01 (0.88, 1.15) 0.881 
2-3 sites 1.16 (1.01, 1.33) 0.035 
4-7 sites 1.12 (0.88, 1.43) 0.339 
Widespread pain 1.34 (0.97, 1.83) 0.072 
*Relative to the probable depression group. 
^ P-value for each level of chronic pain. 
^^ P-value for overall model. 
OR – odds ratio; 95% CI – 95% confidence interval; BMI – body mass index. 
Discussion 
Overall, we found that chronic pain was more commonly reported by individuals with MDD 
(50.4%) than for individuals without a history of mood disorder (38.2%), and was most 
common in those with BD (54.8%). Chronic pain affecting multiple parts of the body 
followed the same pattern. There was a positive relationship between the number of sites of 
chronic pain reported, up to 4–7 sites, and the risk of both BD and MDD. Widespread pain 
was associated with an increased risk of MDD but this was less than those who reported 4–7 
sites of pain; the risk of BD was similar in groups reporting 4–7 sites of pain and widespread 
pain. These significant associations remained after adjusting for potential confounders: age, 
sex, ethnicity, socioeconomic status, employment status, BMI, smoking status, alcohol 
consumption and other long-term conditions. 
Relative to the non-mood disordered group, at all levels of adjustment the RRR of MDD in 
individuals with 4–7 sites of pain was higher than it was in those with widespread pain; 
however, in the BD group the RRR is similar for the two pain groups. It is not clear why this 
might be. There are likely to be differences between individuals who select multiple sites of 
pain, which in essence must be widespread across the body, and those who select the single 
statement to agree that they have “pain all over the body”. These differences may be 
associated with psychological factors. Further work will be needed to try to understand the 
differences between these groups. In the logistic regression model the odds of having BD 
relative to MDD was only significantly higher in the group with 2–3 sites of pain (at each 
level of adjustment for confounders). We expected there to be an increased odds of BD 
relative to MDD as the extent of pain reported increased. However, the number of 
participants with BD and 4–7 sites of pain or widespread pain were 93 and 53, respectively, 
and when potential confounder variables were included in the adjusted models the power to 
detect an association would have decreased. When a suitable larger cohort is available, the 
association of multisite pain with BD in comparison to MDD should be studied further. This 
would help to elucidate reasons for the differences in the relationship of MDD and BD with 
multisite pain. 
These findings are consistent with previous work on the association between chronic pain and 
MDD [1,2] but contribute to the field by reporting on multisite pain syndromes within a very 
large sample of adults aged 40–69 years. We were also able to compare associations across 
two mood disorder groups and a comparison group with no history of mood disorder within a 
single study and we adjusted for a wide range of potentially confounding factors. The 
association between chronic pain and BD has not been extensively studied compared to 
chronic pain and MDD. Our findings, alongside findings from recent clinical and 
epidemiological studies [7,8], suggest that chronic pain is more common in BD than in MDD, 
and that these relationships are independent of sociodemographic, lifestyle and comorbidity 
differences between BD and MDD groups. A meta-analysis of pooled studies of chronic pain 
prevalence in BD, resulting in a sample of over 170,000 individuals with BD, estimated the 
prevalence to be 23.7% [6], much lower than our finding in UK Biobank of chronic pain in 
one or more sites reported by 54.7% of the BD group and to that reported by Failde et al. 
(51.2%) [15]. This is likely to be due to the heterogeneity in both definitions of chronic pain 
and BD across the studies. Our analysis is the largest study to date to consider multisite self-
reported pain in BD and we observed two sites or more of chronic pain in 31.7% of our BD 
group of 1,613 participants. Failde et al. (2013) found 44.5% of their BD study population 
reported pain at two sites or more [15]. The difference observed in prevalence of multisite 
pain may be explained by the study populations considered; in this study we have used a 
large general population based sample and applied BD classifications, whereas Failde et al. 
used a small clinical population diagnosed with BD and also experiencing depressive 
episodes. Patients with BD have been shown to be at a three-fold increased risk of clinically 
reported migraine compared to the general population [6]. Migraine or regional pain sites 
were not a focus of this study but interestingly we found that 13.5% of our BD group reported 
chronic “headache” compared to the 12.3% of the MDD and 5.2% of the control group. 
These initial findings warrant further investigation in the UK Biobank cohort. 
Chronic pain adds to the already challenging treatment of MDD (and vice versa) [16,17]. 
Less is known on how chronic pain impacts the clinical management of BD and severe 
mental illness in general - chronic pain is also common in patients with schizophrenia [18]. 
Given the high prevalence of chronic pain, including multisite pain, in groups with MDD and 
BD it appears that there is certainly a role for assessing pain symptoms and considering pain 
management in the clinical decision making of these patients; both at secondary and primary 
care levels. A more effective role in managing patients with both physical and mental 
morbidities has been called for in both psychiatry [19,20] and general practice [21] and our 
findings support the need for this. 
Mechanisms which might account for the association between chronic pain syndromes and 
depressive disorders are poorly understood, in part because of the heterogeneity within both 
clinical areas and the impact both conditions have on social, psychological and physical 
functioning. A complex interplay of biological, psychological and social factors within 
individuals contributes to the co-occurrence of mood disorders and chronic pain syndromes. 
Possible biological mechanisms include shared genetic predispositions to chronic pain and 
depression [22], common pathophysiological mechanisms (for example, in terms of 
abnormalities of serotonin, norepinephrine, and dopamine neurotransmission in the brain and 
within the peripheral nervous system) [23], as well as oxidative stress [24] and 
immunological theories, including a putative role for proinflammatory cytokines [25,26]. 
Additionally, the likelihood of an individual with chronic pain experiencing significant 
depressive features will be influenced by a broad range of psychological, personality and 
social support factors [27]. Given that we have identified that chronic multisite pain is more 
strongly associated with BD than MDD, and that this association persists after adjusting for 
several important confounders, including other physical morbidities, which are likely to 
impact on an individual’s chronic pain and mood symptom reporting, it is possible that there 
is a significant genetic and neurobiological overlap between severe mood disorders such as 
BD and vulnerability to chronic pain syndromes. 
Although this study makes use of a very large population sample, some potential limitations 
are acknowledged. The data on chronic pain within UK Biobank was self-reported by 
participants, albeit using a structured question approach about seven specific sites of the 
body, which included upper and lower limb, and spinal pain as well as “pain all over the 
body” with a specified duration threshold of three months or longer, which is the widely 
accepted minimum duration for non-malignant pain to be classified as chronic [28]. We were 
limited to data collected by UK Biobank and a measure of pain severity was not available. 
The severity of individuals’ chronic pain symptoms is highly likely to impact on the 
outcomes of these patients. This will be investigated in future work by this research group. 
Our classifications of MDD and BD were based on self-report, rather than formal psychiatric 
examination, although, as with chronic pain assessment, a structured approach was used (see 
“Detailed information of the UK Biobank variables used for classifying lifetime experience 
of probable bipolar disorder and depression” subsection). Psychiatric diagnoses based on 
formal interviews were not possible within UK Biobank and our criteria for probable MDD 
and BD could be considered less stringent than formal diagnostic criteria. Nevertheless, as 
noted above, there were several important internal validators supporting our criteria for MDD 
and BD [11]. For example, the sex distributions of approximately 1:1 for probable BD and 
approximately 2:1 (women:men) for probable MDD are consistent with a large body of 
epidemiological work on lifetime rates of mood disorder in men and women [29,30]. 
Furthermore, the lifetime prevalence rates for bipolar disorder (1.1%) and recurrent major 
depressive disorder (21.3%) are consistent with other population-based lifetime estimates 
[11]. In the future, linkage of UK Biobank participants to routine health records will be 
possible and will enable these definitions to be studied further. This was a cross-sectional 
study and as such it was not possible to determine the temporal relationships between mood 
disorder and pain. However, future work planned will investigate these temporal 
relationships. There is also the potential for recruitment bias as individuals with mood 
disorder may be less likely to participate if they have pain, or vice versa. 
Conclusions 
In summary, to our knowledge, this is the first assessment of the association between chronic 
multisite pain and both MDD and BD within a large and representative population cohort of 
middle to older aged adults. Chronic multisite pain commonly co-occurs with mood 
disorders, particularly BD, even after adjusting for multiple confounders. The risk of a 
probable mood disorder classification (both MDD and BD) also increased in proportion to the 
number of sites of chronic pain reported. These findings have implications for our 
understanding of the neurobiological relationship between chronic pain and mood disorders 
and, within a clinical context, are relevant because they highlight the importance of an 
adequate assessment of the nature and extent of pain in patients with BD or MDD. Further 
work on the UK Biobank cohort will assess whether there are shared genetic and biomarker 
risk factors for chronic pain and BD/MDD and, as prospective health record linkage data 
become available, we will assess the impact of pain and mood disorder comorbidity on 
outcomes for these highly morbid and often challenging clinical groups. 
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